{"transactions":[{"id":735072,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T23:40:50.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in four equal quarterly installments measured from the date of grant."}],"balance_after":7000,"derivative":{"exercise_price":7.13,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001364719-26-000004","document":"form4-06172026_110646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000136471926000004/form4-06172026_110646.xml","form_type":"4"}},{"id":784447,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":784446,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":784445,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":889},"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":784444,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":889},"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":784443,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an \"In-the-Money Option\") was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money\nOption, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":4.46,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":784442,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an \"In-the-Money Option\") was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money\nOption, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":6.7,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":784441,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":26.4,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":784440,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":59.1,"expiration_date":"2028-04-15","underlying":"Common Stock","underlying_shares":389},"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":784439,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T20:30:27.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":false,"shares":6369,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), by and among the Issuer, Aurinia Pharma U.S., Inc. (\"Parent\") and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc.,\n(\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the \"Cash Consideration\"); plus (ii) one non-tradable contingent value right (each, a \"CVR\"), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"CVR Agreement\")"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) without interest and less any applicable tax withholding, upon the achievement of specified milestones in accordance with the terms and subject to the conditions of a CVR Agreement with Broadridge Corporate Issuer Solutions, LLC, as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of\nParent (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), by and among the Issuer, Aurinia Pharma U.S., Inc. (\"Parent\") and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc.,\n(\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the \"Cash Consideration\"); plus (ii) one non-tradable contingent value right (each, a \"CVR\"), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"CVR Agreement\")"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001364719-26-000002","document":"form4-05112026_040513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000136471926000002/form4-05112026_040513.xml","form_type":"4"}},{"id":943083,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of Development"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-08T21:01:11.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests 33.33% of the shares on the first anniversary of January 6, 2026 (the \"Grant Date\"), and an additional 8.33% will vest at the end of each successive three-month period following the first anniversary of the Grant Date until the third anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest) provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":6.88,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-26-002117","document":"tm262491-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465926002117/tm262491-1_4seq1.xml","form_type":"4"}},{"id":988452,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T22:34:12.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":8550,"price":10,"value":85500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 through $10.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":8666,"source":{"system":"sec-edgar","filing":"0001104659-25-116060","document":"tm2532206-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465925116060/tm2532206-3_4seq1.xml","form_type":"4"}},{"id":1103533,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T21:00:17.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/18/2026, subject to Reporting Person continuing to provide service through such date."}],"balance_after":5000,"derivative":{"exercise_price":4.46,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-25-017970","document":"form4-06232025_050612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000141588925017970/form4-06232025_050612.xml","form_type":"4"}},{"id":1120345,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:17:47.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest on the earlier of four equal quarterly installments measured from the date of grant or the date of the next annual meeting of stockholders, subject to the reporting person's continued service at each applicable vest date."}],"balance_after":120000,"derivative":{"exercise_price":0.3051,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001415889-25-015983","document":"form4-06062025_080643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000141588925015983/form4-06062025_080643.xml","form_type":"4"}},{"id":1120344,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:17:47.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal quarterly installments over three years from the date of grant, subject to the reporting person's continued service at each applicable vest date."}],"balance_after":70000,"derivative":{"exercise_price":0.3051,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001415889-25-015983","document":"form4-06062025_080643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000141588925015983/form4-06062025_080643.xml","form_type":"4"}},{"id":1133097,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-27T21:44:21.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2025 to April, 2026 and the last installment shall vest on the earlier of (i) the day before the 2026 Annual Meeting of Stockholders is held or (ii) May 31, 2026, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":7.48,"expiration_date":"2035-05-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-25-053096","document":"tm2516118-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465925053096/tm2516118-4_4seq1.xml","form_type":"4"}},{"id":1133096,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-27T21:44:21.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2025 to April, 2026 and the last installment shall vest on the earlier of (i) the day before the 2026 Annual Meeting of Stockholders is held or (ii) May 31, 2026, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":17216,"source":{"system":"sec-edgar","filing":"0001104659-25-053096","document":"tm2516118-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465925053096/tm2516118-4_4seq1.xml","form_type":"4"}},{"id":1424281,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-23T20:05:45.000Z","date":"2024-08-21","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":26400,"derivative":{"exercise_price":5.195,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0000950170-24-100173","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024100173/ownership.xml","form_type":"4"}},{"id":1424280,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-23T20:05:45.000Z","date":"2024-08-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":2.14,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0000950170-24-100173","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024100173/ownership.xml","form_type":"4"}},{"id":1424279,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-23T20:05:45.000Z","date":"2024-08-21","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":18500,"derivative":{"exercise_price":11.49,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0000950170-24-100173","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024100173/ownership.xml","form_type":"4"}},{"id":1424278,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-23T20:05:45.000Z","date":"2024-08-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":2.14,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0000950170-24-100173","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024100173/ownership.xml","form_type":"4"}},{"id":1424277,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-23T20:05:45.000Z","date":"2024-08-21","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on November 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date."}],"balance_after":37000,"derivative":{"exercise_price":9.39,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0000950170-24-100173","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024100173/ownership.xml","form_type":"4"}},{"id":1424276,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-23T20:05:45.000Z","date":"2024-08-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on November 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.14,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0000950170-24-100173","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024100173/ownership.xml","form_type":"4"}},{"id":1471811,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:20:14.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/20/2025, subject to Reporting Person continuing to provide service through such date."}],"balance_after":50000,"derivative":{"exercise_price":0.67,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-017839","document":"form4-06212024_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000141588924017839/form4-06212024_040609.xml","form_type":"4"}},{"id":1472898,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T00:30:20.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2024 to April, 2025 and the last installment shall vest on the earlier of (i) the day before the 2025 Annual Meeting of Stockholders is held or (ii) May 31, 2025, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":3.27,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-24-073606","document":"tm2417704-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924073606/tm2417704-9_4seq1.xml","form_type":"4"}},{"id":1472897,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-21T00:30:20.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2024 to April, 2025 and the last installment shall vest on the earlier of (i) the day before the 2025 Annual Meeting of Stockholders is held or (ii) May 31, 2025, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":8883,"source":{"system":"sec-edgar","filing":"0001104659-24-073606","document":"tm2417704-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924073606/tm2417704-9_4seq1.xml","form_type":"4"}},{"id":1486845,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:05:19.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":26400,"derivative":{"exercise_price":1.44,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0000950170-24-070605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024070605/ownership.xml","form_type":"4"}},{"id":1486844,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T20:05:19.000Z","date":"2024-06-05","kind":"sale","planned":false,"acquired":false,"shares":5900,"price":1.43,"value":8437.0,"ownership":{"direct":true},"balance_after":5900,"source":{"system":"sec-edgar","filing":"0000950170-24-070605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024070605/ownership.xml","form_type":"4"}},{"id":1486843,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T20:05:19.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":5900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was issued Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":11800,"source":{"system":"sec-edgar","filing":"0000950170-24-070605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024070605/ownership.xml","form_type":"4"}},{"id":1578360,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":16078,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."}],"balance_after":16078,"derivative":{"exercise_price":11.44,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":16078},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1578359,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The canceled stock option was granted on June 28, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from June 2021 to May 2022."}],"balance_after":0,"derivative":{"exercise_price":49.92,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1578358,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The canceled stock option was granted on June 16, 2020 and provided for vesting in twelve equal monthly installments beginning on June 30, 2020 and ending on May 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":21.24,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1578357,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020."}],"balance_after":0,"derivative":{"exercise_price":21.72,"expiration_date":"2029-06-21","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1578356,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on July 11, 2018 ending on June 11, 2019."}],"balance_after":0,"derivative":{"exercise_price":67.08,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1578355,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The canceled stock option was granted on June 13, 2017 and provided for vesting in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017."}],"balance_after":0,"derivative":{"exercise_price":25.08,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1578354,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The canceled stock option was granted on June 14, 2016 and provided for vesting in twelve monthly installments through June 14, 2017, with the first monthly installment vesting on July 14, 2016."}],"balance_after":0,"derivative":{"exercise_price":16.44,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1578353,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1497,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The canceled stock option was granted on June 12, 2015 and provided for vesting in twelve monthly installments through June 12, 2016, with the first monthly installment vesting on July 12, 2015."}],"balance_after":0,"derivative":{"exercise_price":95.88,"expiration_date":"2025-06-11","underlying":"Common Stock","underlying_shares":1497},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1578352,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-13T22:07:37.000Z","date":"2024-03-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The canceled stock option was granted on June 10, 2014 and provided for vesting in twelve equal monthly installments from June 10, 2014 until June 10, 2015."}],"balance_after":0,"derivative":{"exercise_price":120.84,"expiration_date":"2024-06-10","underlying":"Common Stock","underlying_shares":2083},"source":{"system":"sec-edgar","filing":"0001104659-24-034034","document":"tm248737-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465924034034/tm248737-1_4seq1.xml","form_type":"4"}},{"id":1805854,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:07:02.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service on the Issuer's Board of Directors is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in full on the earlier to occur of (a) June 1, 2024 or (b) the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date."}],"balance_after":26400,"derivative":{"exercise_price":2.14,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001209191-23-046095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046095/doc4.xml","form_type":"4"}},{"id":1805853,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:07:02.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in full on the earlier to occur of (a) June 1, 2024 or (b) the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.195,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001209191-23-046095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046095/doc4.xml","form_type":"4"}},{"id":1805852,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:07:02.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service on the Issuer's Board of Directors is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":18500,"derivative":{"exercise_price":2.14,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-23-046095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046095/doc4.xml","form_type":"4"}},{"id":1805851,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:07:02.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":11.49,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-23-046095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046095/doc4.xml","form_type":"4"}},{"id":1805850,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:07:02.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service on the Issuer's Board of Directors is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on November 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date."}],"balance_after":37000,"derivative":{"exercise_price":2.14,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001209191-23-046095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046095/doc4.xml","form_type":"4"}},{"id":1805849,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:07:02.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on November 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.39,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001209191-23-046095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046095/doc4.xml","form_type":"4"}},{"id":1822734,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T21:04:18.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":26000,"derivative":{"exercise_price":2.28,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123043439/doc4.xml","form_type":"4"}},{"id":1822733,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T21:04:18.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123043439/doc4.xml","form_type":"4"}},{"id":1822732,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T21:04:18.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":26000,"derivative":{"exercise_price":2.28,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123043439/doc4.xml","form_type":"4"}},{"id":1822731,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T21:04:18.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.59,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123043439/doc4.xml","form_type":"4"}},{"id":1822730,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T21:04:18.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":8896,"derivative":{"exercise_price":2.28,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-23-043439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123043439/doc4.xml","form_type":"4"}},{"id":1822729,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T21:04:18.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-23-043439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123043439/doc4.xml","form_type":"4"}},{"id":1822728,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T21:04:18.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":8896,"derivative":{"exercise_price":2.28,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-23-043439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123043439/doc4.xml","form_type":"4"}},{"id":1822727,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T21:04:18.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.63,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-23-043439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123043439/doc4.xml","form_type":"4"}},{"id":1851648,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:36:32.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/15/2024, subject to Reporting Person continuing to provide service through such date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-037927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919123037927/doc4.xml","form_type":"4"}},{"id":1870046,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T21:48:49.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares shall vest in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":26400,"derivative":{"exercise_price":5.195,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001209191-23-033959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123033959/doc4.xml","form_type":"4"}},{"id":1870045,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T21:48:49.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":5900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was issued Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":5900,"source":{"system":"sec-edgar","filing":"0001209191-23-033959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123033959/doc4.xml","form_type":"4"}},{"id":1891107,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-16T20:34:54.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2023 to April, 2024 and the last installment shall vest on the earlier of (i) the day before the 2024 Annual Meeting of Stockholders is held or (ii) May 31, 2024, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.42,"expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001104659-23-061426","document":"tm2315836-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465923061426/tm2315836-7_4seq1.xml","form_type":"4"}},{"id":2079520,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-12-20T21:07:42.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 24, 2022 the Reporting Person filed a Form 4 reporting a stock option grant which incorrectly stated an exercise price of $1.11, a transaction date of June 22, 2022 and an expiration date of June 22, 2032. This amendment is being filed to reflect the corrected exercise price of $1.07, transaction date of May 12, 2022 and expiration date of May 12, 2032."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in twelve equal month installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest) beginning on the on the last day of each month over a period from June, 2022 to May, 2023, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":1.07,"expiration_date":"2032-05-12","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001104659-22-128633","document":"tm2232937-5_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465922128633/tm2232937-5_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-06-24"}},{"id":2221850,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:10:33.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in twelve equal month installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest) beginning on the on the last day of each month over a period from June, 2022 to May, 2023, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":1.11,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001104659-22-074308","document":"tm2219034-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465922074308/tm2219034-7_4seq1.xml","form_type":"4"}},{"id":2227110,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T22:04:44.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/16/2023, subject to Reporting Person continuing to provide service through such date."}],"balance_after":26000,"derivative":{"exercise_price":4.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-22-038050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122038050/doc4.xml","form_type":"4"}},{"id":2244882,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T20:38:45.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares shall vest in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":18500,"derivative":{"exercise_price":11.49,"expiration_date":"2032-06-01","underlying":"Common stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-22-034088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122034088/doc4.xml","form_type":"4"}},{"id":2359786,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-02T20:18:21.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on February 28, 2022 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":27000,"derivative":{"exercise_price":10.33,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-22-014624","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122014624/doc4.xml","form_type":"4"}},{"id":2359785,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-02T20:18:21.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":6226,"price":10.2375,"value":63738.675,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the spouse of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $10.24 to $10.35, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":898131,"source":{"system":"sec-edgar","filing":"0001209191-22-014624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122014624/doc4.xml","form_type":"4"}},{"id":2359784,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-02T20:18:21.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":6226,"price":10.2375,"value":63738.675,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $10.24 to $10.35, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":713757,"source":{"system":"sec-edgar","filing":"0001209191-22-014624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122014624/doc4.xml","form_type":"4"}},{"id":2359783,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-02T20:18:21.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\").  RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.  The RSUs vest in four equal annual installments beginning February 28, 2023."}],"balance_after":719983,"source":{"system":"sec-edgar","filing":"0001209191-22-014624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122014624/doc4.xml","form_type":"4"}},{"id":2381746,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-22T21:14:15.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":9088,"price":12.1234,"value":110177.4592,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the spouse of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price of the spouse of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":904357,"source":{"system":"sec-edgar","filing":"0001209191-22-011636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122011636/doc4.xml","form_type":"4"}},{"id":2381745,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-22T21:14:15.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":9079,"price":12.1234,"value":110068.3486,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":698983,"source":{"system":"sec-edgar","filing":"0001209191-22-011636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122011636/doc4.xml","form_type":"4"}},{"id":2406071,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-09T22:24:24.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":6707,"price":9.862,"value":66144.434,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the spouse of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price of the spouse of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":913445,"source":{"system":"sec-edgar","filing":"0001209191-22-008124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122008124/doc4.xml","form_type":"4"}},{"id":2406070,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-09T22:24:24.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":6764,"price":9.862,"value":66706.568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":708062,"source":{"system":"sec-edgar","filing":"0001209191-22-008124","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122008124/doc4.xml","form_type":"4"}},{"id":2443082,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T23:51:52.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":3896,"derivative":{"exercise_price":5.91,"expiration_date":"2028-04-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-001964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122001964/doc4.xml","form_type":"4"}},{"id":2443081,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T23:51:52.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":5000,"price":16.45,"value":82250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.164 to $16.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":63690,"source":{"system":"sec-edgar","filing":"0001209191-22-001964","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122001964/doc4.xml","form_type":"4"}},{"id":2443080,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T23:51:52.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":5000,"price":5.91,"value":29550.0,"ownership":{"direct":true},"balance_after":68690,"source":{"system":"sec-edgar","filing":"0001209191-22-001964","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919122001964/doc4.xml","form_type":"4"}},{"id":2504947,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to Buy)","published_at":"2021-11-18T12:13:26.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares shall vest in thirty-six (36) equal monthly installments beginning November 17, 2021."}],"balance_after":37000,"derivative":{"exercise_price":9.39,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001209191-21-065375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121065375/doc4.xml","form_type":"4"}},{"id":2649523,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-30T22:47:46.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/28/2022, subject to Reporting Person continuing to provide service through such date."}],"balance_after":26000,"derivative":{"exercise_price":5.59,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-21-044085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121044085/doc4.xml","form_type":"4"}},{"id":2649522,"issuer":{"id":5242,"kind":"organization","name":"Verastem, Inc.","symbol":"VSTM"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-30T17:56:13.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in twelve equal month installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest) beginning on the on the last day of each month over a period from June, 2021 to May, 2022, provided that the Reporting Person continues to serve as a director of the Company on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":4.16,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-087398","document":"tm2121071-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000110465921087398/tm2121071-1_4seq1.xml","form_type":"4"}},{"id":2774324,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-23T11:48:13.000Z","date":"2021-03-18","kind":"sale","acquired":false,"shares":4000,"price":12.3882,"value":49552.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $12.29 to $12.56, inclusive.  The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":714826,"source":{"system":"sec-edgar","filing":"0001209191-21-022486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121022486/doc4.xml","form_type":"4"}},{"id":2825634,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T01:09:00.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":153500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 25, 2021 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 25, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":153500,"derivative":{"exercise_price":14.56,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":153500},"source":{"system":"sec-edgar","filing":"0001209191-21-015481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121015481/doc4.xml","form_type":"4"}},{"id":2825633,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T01:09:00.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":153500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 25, 2021 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 25, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":153500,"derivative":{"exercise_price":14.56,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":153500},"source":{"system":"sec-edgar","filing":"0001209191-21-015481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121015481/doc4.xml","form_type":"4"}},{"id":2825632,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-02T01:09:00.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":57200,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 25, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The spouse of the reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 57,200 newly awarded RSUs, 86,500 RSUs previously reported in Table II, and 776,452 shares of common stock."}],"balance_after":920152,"source":{"system":"sec-edgar","filing":"0001209191-21-015481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121015481/doc4.xml","form_type":"4"}},{"id":2825631,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-02T01:09:00.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":57200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 25, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 57,200 newly awarded RSUs, 86,500 RSUs previously reported in Table II, and 575,126 shares of common stock."}],"balance_after":718826,"source":{"system":"sec-edgar","filing":"0001209191-21-015481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121015481/doc4.xml","form_type":"4"}},{"id":2842826,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-23T01:09:33.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":9495,"price":14.8312,"value":140822.244,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the spouse of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price of the spouse of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 18, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":776452,"source":{"system":"sec-edgar","filing":"0001209191-21-012960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121012960/doc4.xml","form_type":"4"}},{"id":2842825,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-23T01:09:33.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":9495,"price":14.8312,"value":140822.244,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 18, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":575126,"source":{"system":"sec-edgar","filing":"0001209191-21-012960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121012960/doc4.xml","form_type":"4"}},{"id":2853734,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-17T23:44:21.000Z","date":"2021-02-15","kind":"exercise","acquired":false,"shares":21800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On February 15, 2019, the spouse of the reporting person was granted 87,200 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on February 15, 2021. Vested shares will be delivered to the spouse of the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On February 15, 2019, the spouse of the reporting person was granted 87,200 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on February 15, 2021. Vested shares will be delivered to the spouse of the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":43600,"derivative":{"underlying":"Common Stock","underlying_shares":21800},"source":{"system":"sec-edgar","filing":"0001209191-21-011484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121011484/doc4.xml","form_type":"4"}},{"id":2853733,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-17T23:44:21.000Z","date":"2021-02-15","kind":"exercise","acquired":false,"shares":21800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On February 15, 2019, the reporting person was granted 87,200 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On February 15, 2019, the reporting person was granted 87,200 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":43600,"derivative":{"underlying":"Common Stock","underlying_shares":21800},"source":{"system":"sec-edgar","filing":"0001209191-21-011484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121011484/doc4.xml","form_type":"4"}},{"id":2853732,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:44:21.000Z","date":"2021-02-15","kind":"exercise","acquired":true,"shares":21800,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."}],"balance_after":785947,"source":{"system":"sec-edgar","filing":"0001209191-21-011484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121011484/doc4.xml","form_type":"4"}},{"id":2853731,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:44:21.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":6642,"price":15.519,"value":103077.198,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the spouse of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price of the spouse of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 11, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":764147,"source":{"system":"sec-edgar","filing":"0001209191-21-011484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121011484/doc4.xml","form_type":"4"}},{"id":2853730,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:44:21.000Z","date":"2021-02-15","kind":"exercise","acquired":true,"shares":21800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."}],"balance_after":584621,"source":{"system":"sec-edgar","filing":"0001209191-21-011484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121011484/doc4.xml","form_type":"4"}},{"id":2853729,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:44:21.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":6601,"price":15.519,"value":102440.919,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 11, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":562821,"source":{"system":"sec-edgar","filing":"0001209191-21-011484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121011484/doc4.xml","form_type":"4"}},{"id":2871382,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-10T01:28:15.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":14300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 5, 2020, the spouse of the reporting person was granted 57,200 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on February 5, 2021. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 5, 2020, the spouse of the reporting person was granted 57,200 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on February 5, 2021. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":42900,"derivative":{"underlying":"Common Stock","underlying_shares":14300},"source":{"system":"sec-edgar","filing":"0001209191-21-009070","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121009070/doc4.xml","form_type":"4"}},{"id":2871381,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-10T01:28:15.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":14300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 5, 2020, the reporting person was granted 57,200 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 5, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 5, 2020, the reporting person was granted 57,200 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 5, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":42900,"derivative":{"underlying":"Common Stock","underlying_shares":14300},"source":{"system":"sec-edgar","filing":"0001209191-21-009070","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121009070/doc4.xml","form_type":"4"}},{"id":2871380,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-10T01:28:15.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":14300,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."}],"balance_after":770789,"source":{"system":"sec-edgar","filing":"0001209191-21-009070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121009070/doc4.xml","form_type":"4"}},{"id":2871379,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-10T01:28:15.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":14300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."}],"balance_after":569422,"source":{"system":"sec-edgar","filing":"0001209191-21-009070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919121009070/doc4.xml","form_type":"4"}},{"id":3006927,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T21:56:31.000Z","date":"2020-10-12","kind":"exercise","acquired":false,"shares":6076,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.033,"expiration_date":"2020-10-31","underlying":"Common Stock","underlying_shares":6076},"source":{"system":"sec-edgar","filing":"0001209191-20-054822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120054822/doc4.xml","form_type":"4"}},{"id":3006926,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T21:56:31.000Z","date":"2020-10-12","kind":"exercise","acquired":false,"shares":1424,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.033,"expiration_date":"2020-10-31","underlying":"Common Stock","underlying_shares":1424},"source":{"system":"sec-edgar","filing":"0001209191-20-054822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120054822/doc4.xml","form_type":"4"}},{"id":3006925,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-14T21:56:31.000Z","date":"2020-10-12","kind":"sale","acquired":false,"shares":7500,"price":14.891,"value":111682.5,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $14.71 to $15.16, inclusive.  The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":756489,"source":{"system":"sec-edgar","filing":"0001209191-20-054822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120054822/doc4.xml","form_type":"4"}},{"id":3006924,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-14T21:56:31.000Z","date":"2020-10-12","kind":"exercise","acquired":true,"shares":6076,"price":0.033,"value":200.508,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."}],"balance_after":763989,"source":{"system":"sec-edgar","filing":"0001209191-20-054822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120054822/doc4.xml","form_type":"4"}},{"id":3006923,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-14T21:56:31.000Z","date":"2020-10-12","kind":"exercise","acquired":true,"shares":1424,"price":0.033,"value":46.992,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."}],"balance_after":757913,"source":{"system":"sec-edgar","filing":"0001209191-20-054822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120054822/doc4.xml","form_type":"4"}},{"id":3053665,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-18T22:07:06.000Z","date":"2020-08-17","kind":"exercise","acquired":false,"shares":1477,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter."}],"balance_after":6076,"derivative":{"exercise_price":0.033,"expiration_date":"2020-10-31","underlying":"Common Stock","underlying_shares":1477},"source":{"system":"sec-edgar","filing":"0001209191-20-047279","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120047279/doc4.xml","form_type":"4"}},{"id":3053664,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-18T22:07:06.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":1477,"price":15,"value":22155.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."}],"balance_after":756489,"source":{"system":"sec-edgar","filing":"0001209191-20-047279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120047279/doc4.xml","form_type":"4"}},{"id":3053663,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-18T22:07:06.000Z","date":"2020-08-17","kind":"exercise","acquired":true,"shares":1477,"price":0.033,"value":48.741,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."}],"balance_after":757966,"source":{"system":"sec-edgar","filing":"0001209191-20-047279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120047279/doc4.xml","form_type":"4"}},{"id":3080187,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":37452,"kind":"person","name":"Kauffman Michael","position":1,"cik":"0001364719","reported_name":"Kauffman Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-17T20:26:02.000Z","date":"2020-07-15","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on November 1, 2011, and the remaining 75% vested in 36 equal monthly installments thereafter."}],"balance_after":1424,"derivative":{"exercise_price":0.033,"expiration_date":"2020-10-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-042845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1364719/000120919120042845/doc4.xml","form_type":"4"}}],"next_cursor":"2020-07-17T20:26:02.000000Z,3080187"}